Korean Nasal Congestion Surgery Medical Device Expands into Malaysia
T&R Biofab Signs Supply Contract for 'D&R Nasal Mesh' in Malaysia
Fifth Market Entry Following Vietnam, Thailand, Philippines, and Taiwan
[Asia Economy Reporter Minwoo Lee] 3D bioprinting specialist T&R Biofab is starting to export medical devices to Malaysia.
T&R Biofab announced on the 20th that it has signed a contract with BioPro Services, a local medical device import and distribution specialist company, to supply 'D&L Nasal Mesh,' an absorbable synthetic polymer material produced through 3D bioprinting, to Malaysia.
'D&L Nasal Mesh' is a biodegradable artificial support product used in septoplasty to improve symptoms related to nasal congestion (nasal obstruction). It is used to temporarily support the nasal septum for reconstruction and restoration of the affected area.
Under this contract, BioPro Services will hold exclusive sales rights for this product in Malaysia and will handle local regulatory approval, distribution, and sales. Established in 2004, BioPro Services exclusively imports products verified for quality and safety from Korea, Germany, Spain, China, and supplies them to over 60 general hospitals and private ENT clinics throughout Malaysia.
As of last year, the Malaysian medical device market size reached approximately $1.51 billion, growing 2.4% compared to the previous year. The medical device industry structure is weak relative to demand, and especially in fields requiring advanced technology, much of the supply depends on imports, making it an important potential market for T&R Biofab.
Meanwhile, with this contract, T&R Biofab has expanded into five Asian countries including Vietnam, Thailand, the Philippines, and Taiwan.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Yoon Won-soo, CEO of T&R Biofab, stated, "Through continuous global market expansion strategies, we will gradually strengthen the marketability of 3D bioprinting medical devices."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.